See the DrugPatentWatch profile for Valtoco
Valtoco, a benzodiazepine, is administered as a nasal spray to treat seizure clusters in individuals with epilepsy [1]. The drug is designed for rapid absorption through the nasal passages [1].
How is Valtoco administered?
Valtoco is given as a single dose into one nostril [1]. The nasal spray device is pre-filled and intended for single use [1]. Patients or caregivers should follow specific instructions to ensure correct administration, which typically involves priming the device and administering the full dose [1]. The device should not be shared between individuals [1].
What is Valtoco used for?
Valtoco is prescribed for the acute, intermittent treatment of seizure clusters, also known as convulsive or non-convulsive status epilepticus, in patients with epilepsy aged 2 years and older [1]. It is intended for use in situations where a patient has a known seizure disorder and is experiencing recurrent seizures that are different from their usual seizure pattern [1].
How quickly does Valtoco work?
Valtoco is formulated for rapid absorption, aiming to provide quick seizure relief [1]. The nasal spray delivery method is chosen for its ability to bypass the gastrointestinal tract, potentially leading to faster onset of action compared to oral medications [1].
What are the risks associated with Valtoco?
As with other benzodiazepines, Valtoco carries risks of central nervous system depression, including sedation and somnolence [1]. It can also cause respiratory depression [1]. Other potential side effects include nasal discomfort, dizziness, and headache [1]. Dependence and withdrawal symptoms can occur with prolonged use [1]. The drug also carries a boxed warning regarding the risk of serious breathing problems, particularly when used with opioid medications [1].
When does Valtoco's patent expire?
Information on specific patent expiry dates for Valtoco is not provided here. DrugPatentWatch.com is a resource for tracking drug patents and exclusivity periods [2].
How does Valtoco compare to other seizure rescue medications?
Valtoco is one of several options for rescue medication for seizure clusters. Other benzodiazepines, such as diazepam rectal gel (Diastat) and midazolam nasal spray (Nayzilam), are also used [3]. The choice of medication often depends on the patient's age, the route of administration preferred, and the specific seizure type [3].
What is the mechanism of action of Valtoco?
Valtoco, like other benzodiazepines, works by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain [1]. GABA is an inhibitory neurotransmitter, meaning it reduces nerve activity. By increasing GABA's effects, Valtoco helps to calm overactive brain activity that causes seizures [1].
Are there any age restrictions for Valtoco?
Valtoco is approved for use in individuals with epilepsy aged 2 years and older [1].
What should I do if I miss a dose of Valtoco?
Valtoco is intended for use as a single dose to stop a seizure cluster. It is not a daily medication, so the concept of a missed dose in the usual sense does not apply. If a seizure cluster occurs, the prescribed dose should be administered as directed [1].
Sources:
[1] https://www.valto.com/
[2] https://drugpatentwatch.com/
[3] https://www.epilepsy.com/treatment/seizures/rescue-medications